TW200621720A - Crystalline forms of a factor xa inhibitor - Google Patents

Crystalline forms of a factor xa inhibitor

Info

Publication number
TW200621720A
TW200621720A TW094133785A TW94133785A TW200621720A TW 200621720 A TW200621720 A TW 200621720A TW 094133785 A TW094133785 A TW 094133785A TW 94133785 A TW94133785 A TW 94133785A TW 200621720 A TW200621720 A TW 200621720A
Authority
TW
Taiwan
Prior art keywords
crystalline forms
inhibitor
factor
oxo
pharmaceutical compositions
Prior art date
Application number
TW094133785A
Other languages
Chinese (zh)
Inventor
Margaret M Gleeson
Gary Mcgeorge
Bang-Chi Chen
Hui-Ping Zhang
Mary F Malley
Denette K Murphy
Xiaotian S Yin
Steven R Fabian
Jasmine M Gupta
Huiping Zhang
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of TW200621720A publication Critical patent/TW200621720A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The instant invention provides crystalline forms of 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and its solvates thereof; processes for the production of such crystalline forms; pharmaceutical compositions comprising such crystalline forms; and methods of treating thromboembolic disorders with such crystalline forms or such pharmaceutical compositions.
TW094133785A 2004-09-28 2005-09-28 Crystalline forms of a factor xa inhibitor TW200621720A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61365604P 2004-09-28 2004-09-28

Publications (1)

Publication Number Publication Date
TW200621720A true TW200621720A (en) 2006-07-01

Family

ID=38134425

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094133785A TW200621720A (en) 2004-09-28 2005-09-28 Crystalline forms of a factor xa inhibitor

Country Status (5)

Country Link
CN (1) CN101065378A (en)
AR (1) AR054086A1 (en)
PE (1) PE20060698A1 (en)
TW (1) TW200621720A (en)
ZA (1) ZA200702485B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111704612A (en) * 2015-12-08 2020-09-25 浙江亚太药业股份有限公司 P crystal form of pyridine derivative, and preparation method and application thereof

Also Published As

Publication number Publication date
PE20060698A1 (en) 2006-07-09
CN101065378A (en) 2007-10-31
ZA200702485B (en) 2008-11-26
AR054086A1 (en) 2007-06-06

Similar Documents

Publication Publication Date Title
ZA200306419B (en) Phenyl derivatives.
CA2603830A1 (en) Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
MY148809A (en) Crystals of 1,2-dihydropyridine compound and their production process
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
HK1065033A1 (en) Thiazole compounds useful as inhibitors or proteinkinases
MX2009007050A (en) Carboxamide compounds and their use as calpain inhibitors.
WO2006013095A3 (en) Condensed pyridines as kinase inhibitors
AU2003297160A1 (en) Benzisoxazole derivatives useful as inhibitors of protein kinases
MY141780A (en) 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
NO20062256L (en) Hydroxyalkyl-substituted pyrido-7-pyrimidin-7-ones
MX2009005217A (en) Nitrogen-containing heterocyclic compounds and methods of use thereof.
WO2006061417A3 (en) Macrocyclic quinazole derivatives and their use as mtki
MX2009003763A (en) Heterocyclic derived metalloprotease inhibitors.
NO20064351L (en) Caspase Inhibitors and Uses thereof
MXPA05011962A (en) Substituted oxyarenes, and use thereof for controlling pests.
NO20063220L (en) Tricyclic imidazopyridines for use as gastric secretion inhibitors
WO2004032908A3 (en) Method of inhibiting angiogenesis
MX2007003426A (en) Crytalline forms of a pyrazolo `3, 4-c ! pyridine factor xa inhibitor.
MXPA03001356A (en) Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments.
TW200634011A (en) Crystalline forms of a factor xa inhibitor
GB0412314D0 (en) Compounds
MXPA03010205A (en) Oxalic acid derivatives.
TW200621720A (en) Crystalline forms of a factor xa inhibitor
EP1736472A4 (en) 2-aminopyridine derivative
WO2005075456A8 (en) 2-(piperidin-4-yl) -4, 5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors